Th17/IL-17A might play a protective role in chronic lymphocytic leukemia immunity.

por Iwona Hus, Agnieszka Bojarska-Junak, Sylwia Chocholska, Waldemar Tomczak, Justyna Woś, Anna Dmoszyńska, Jacek Roliński, Jacek Roliński
Publicado 2013

Programmed death-1 and its ligand are novel immunotolerant molecules expressed on leukemic B cells in chronic lymphocytic leukemia.

por Maciej Grzywnowicz, Joanna Zaleska, Daniel Mertens, Waldemar Tomczak, Paulina Wlasiuk, Kamila Kosior, Agnieszka Piechnik, Agnieszka Bojarska-Junak, Anna Dmoszynska, Krzysztof Giannopoulos
Publicado 2012